Warning: Undefined array key "network" in /hshare1/ZETTAI_path_WA_slash_usr_slash_proj_KARA/usr/proj/tcng/htdocs/tcng.php on line 565
Edge
HMGCR → KPNA1
Networks Including this Edge
| GSE10445_egf1520 - GSE10445 - SiGN-BN HC+Bootstrap | MERLION LUNG CANCER STUDY |
| GSE10797_egf1520 - GSE10797 - SiGN-BN HC+Bootstrap | Transcriptomes of breast epithelium and stroma in normal reduction mammoplasty and invasive breast cancer patients. |
| GSE11121_egf1520 - GSE11121 - SiGN-BN HC+Bootstrap | The humoral immune system has a key prognostic impact in node-negative breast cancer |
| GSE14814_egf1520 - GSE14814 - SiGN-BN HC+Bootstrap | Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer |
| GSE16455_egf1520 - GSE16455 - SiGN-BN HC+Bootstrap | Indolent MCL identified by genomic and gene expression profiling |
| GSE24080_egf1520 - GSE24080 - SiGN-BN HC+Bootstrap | MAQC-II Project: Multiple myeloma (MM) data set |
| GSE24185_egf1520 - GSE24185 - SiGN-BN HC+Bootstrap | Gene transcription signature of obesity in breast cancer |
| GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| GSE3141_egf1520 - GSE3141 - SiGN-BN HC+Bootstrap | Lung Cancer Dataset |
| GSE4581_egf1520 - GSE4581 - SiGN-BN HC+Bootstrap | Gene Expression Profiles of Multiple Myeloma (N=414) Before Treatment |
| GSE6465_egf1520 - GSE6465 - SiGN-BN HC+Bootstrap | Expression data of Hepatocellular Carcinoma |
| GSE7670_egf1520 - GSE7670 - SiGN-BN HC+Bootstrap | Expression data from Lung cancer |
